AKR1B10 and metabolic dysfunction-associated steatotic liver disease: High insulin levels and insulin resistance are present in NAFLD, especially in NASH, and this could also contribute to the increased AKR1B10 expression.[40] This relationship was also suggested in our previous study[18] where HOMA-IR correlated positively with AKR1B10 expression.